The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Pet Medication-Global Market Insights and Sales Trends 2024

Pet Medication-Global Market Insights and Sales Trends 2024

Publishing Date : Nov, 2023

License Type :
 

Report Code : 1832940

No of Pages : 114

Ask Your Query
Synopsis
The global Pet Medication market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Pet Medication in various end use industries. The expanding demands from the Cat, Dog, Horse and Fish, are propelling Pet Medication market. Antibiotics, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Antifungal segment is estimated at % CAGR for the next seven-year period.
According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly €6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 46%.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Pet Medication, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Pet Medication market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Pet Medication market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Pet Medication sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Pet Medication covered in this report include Zoetis, Merck, Elanco, Bayer, Boehringer, Novartis, Virbac, Ceva and Vetoquinol, etc.
The global Pet Medication market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Zoetis
Merck
Elanco
Bayer
Boehringer
Novartis
Virbac
Ceva
Vetoquinol
Nexvet
Aratana Therapeutics
Kindred Biosciences
Ambrx
Entest Biomedical
Taconic Biosciences
Global Pet Medication market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Pet Medication market, Segment by Type:
Antibiotics
Antifungal
Flea Products
Global Pet Medication market, by Application
Cat
Dog
Horse
Fish
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Pet Medication manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Pet Medication in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 Pet Medication Market Overview
1.1 Pet Medication Product Overview
1.2 Pet Medication Market Segment by Type
1.2.1 Antibiotics
1.2.2 Antifungal
1.2.3 Flea Products
1.3 Global Pet Medication Market Size by Type
1.3.1 Global Pet Medication Market Size Overview by Type (2018-2029)
1.3.2 Global Pet Medication Historic Market Size Review by Type (2018-2023)
1.3.3 Global Pet Medication Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Pet Medication Sales Breakdown by Type (2018-2023)
1.4.2 Europe Pet Medication Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Pet Medication Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Pet Medication Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Pet Medication Sales Breakdown by Type (2018-2023)
2 Global Pet Medication Market Competition by Company
2.1 Global Top Players by Pet Medication Sales (2018-2023)
2.2 Global Top Players by Pet Medication Revenue (2018-2023)
2.3 Global Top Players by Pet Medication Price (2018-2023)
2.4 Global Top Manufacturers Pet Medication Manufacturing Base Distribution, Sales Area, Product Type
2.5 Pet Medication Market Competitive Situation and Trends
2.5.1 Pet Medication Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Pet Medication Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pet Medication as of 2022)
2.7 Date of Key Manufacturers Enter into Pet Medication Market
2.8 Key Manufacturers Pet Medication Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Pet Medication Status and Outlook by Region
3.1 Global Pet Medication Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Pet Medication Historic Market Size by Region
3.2.1 Global Pet Medication Sales in Volume by Region (2018-2023)
3.2.2 Global Pet Medication Sales in Value by Region (2018-2023)
3.2.3 Global Pet Medication Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Pet Medication Forecasted Market Size by Region
3.3.1 Global Pet Medication Sales in Volume by Region (2024-2029)
3.3.2 Global Pet Medication Sales in Value by Region (2024-2029)
3.3.3 Global Pet Medication Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Pet Medication by Application
4.1 Pet Medication Market Segment by Application
4.1.1 Cat
4.1.2 Dog
4.1.3 Horse
4.1.4 Fish
4.1.5 Others
4.2 Global Pet Medication Market Size by Application
4.2.1 Global Pet Medication Market Size Overview by Application (2018-2029)
4.2.2 Global Pet Medication Historic Market Size Review by Application (2018-2023)
4.2.3 Global Pet Medication Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Pet Medication Sales Breakdown by Application (2018-2023)
4.3.2 Europe Pet Medication Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Pet Medication Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Pet Medication Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Pet Medication Sales Breakdown by Application (2018-2023)
5 North America Pet Medication by Country
5.1 North America Pet Medication Historic Market Size by Country
5.1.1 North America Pet Medication Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Pet Medication Sales in Volume by Country (2018-2023)
5.1.3 North America Pet Medication Sales in Value by Country (2018-2023)
5.2 North America Pet Medication Forecasted Market Size by Country
5.2.1 North America Pet Medication Sales in Volume by Country (2024-2029)
5.2.2 North America Pet Medication Sales in Value by Country (2024-2029)
6 Europe Pet Medication by Country
6.1 Europe Pet Medication Historic Market Size by Country
6.1.1 Europe Pet Medication Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Pet Medication Sales in Volume by Country (2018-2023)
6.1.3 Europe Pet Medication Sales in Value by Country (2018-2023)
6.2 Europe Pet Medication Forecasted Market Size by Country
6.2.1 Europe Pet Medication Sales in Volume by Country (2024-2029)
6.2.2 Europe Pet Medication Sales in Value by Country (2024-2029)
7 Asia-Pacific Pet Medication by Region
7.1 Asia-Pacific Pet Medication Historic Market Size by Region
7.1.1 Asia-Pacific Pet Medication Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Pet Medication Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Pet Medication Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Pet Medication Forecasted Market Size by Region
7.2.1 Asia-Pacific Pet Medication Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Pet Medication Sales in Value by Region (2024-2029)
8 Latin America Pet Medication by Country
8.1 Latin America Pet Medication Historic Market Size by Country
8.1.1 Latin America Pet Medication Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Pet Medication Sales in Volume by Country (2018-2023)
8.1.3 Latin America Pet Medication Sales in Value by Country (2018-2023)
8.2 Latin America Pet Medication Forecasted Market Size by Country
8.2.1 Latin America Pet Medication Sales in Volume by Country (2024-2029)
8.2.2 Latin America Pet Medication Sales in Value by Country (2024-2029)
9 Middle East and Africa Pet Medication by Country
9.1 Middle East and Africa Pet Medication Historic Market Size by Country
9.1.1 Middle East and Africa Pet Medication Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Pet Medication Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Pet Medication Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Pet Medication Forecasted Market Size by Country
9.2.1 Middle East and Africa Pet Medication Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Pet Medication Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Zoetis
10.1.1 Zoetis Company Information
10.1.2 Zoetis Introduction and Business Overview
10.1.3 Zoetis Pet Medication Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Zoetis Pet Medication Products Offered
10.1.5 Zoetis Recent Development
10.2 Merck
10.2.1 Merck Company Information
10.2.2 Merck Introduction and Business Overview
10.2.3 Merck Pet Medication Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Merck Pet Medication Products Offered
10.2.5 Merck Recent Development
10.3 Elanco
10.3.1 Elanco Company Information
10.3.2 Elanco Introduction and Business Overview
10.3.3 Elanco Pet Medication Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Elanco Pet Medication Products Offered
10.3.5 Elanco Recent Development
10.4 Bayer
10.4.1 Bayer Company Information
10.4.2 Bayer Introduction and Business Overview
10.4.3 Bayer Pet Medication Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Bayer Pet Medication Products Offered
10.4.5 Bayer Recent Development
10.5 Boehringer
10.5.1 Boehringer Company Information
10.5.2 Boehringer Introduction and Business Overview
10.5.3 Boehringer Pet Medication Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Boehringer Pet Medication Products Offered
10.5.5 Boehringer Recent Development
10.6 Novartis
10.6.1 Novartis Company Information
10.6.2 Novartis Introduction and Business Overview
10.6.3 Novartis Pet Medication Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Novartis Pet Medication Products Offered
10.6.5 Novartis Recent Development
10.7 Virbac
10.7.1 Virbac Company Information
10.7.2 Virbac Introduction and Business Overview
10.7.3 Virbac Pet Medication Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Virbac Pet Medication Products Offered
10.7.5 Virbac Recent Development
10.8 Ceva
10.8.1 Ceva Company Information
10.8.2 Ceva Introduction and Business Overview
10.8.3 Ceva Pet Medication Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Ceva Pet Medication Products Offered
10.8.5 Ceva Recent Development
10.9 Vetoquinol
10.9.1 Vetoquinol Company Information
10.9.2 Vetoquinol Introduction and Business Overview
10.9.3 Vetoquinol Pet Medication Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Vetoquinol Pet Medication Products Offered
10.9.5 Vetoquinol Recent Development
10.10 Nexvet
10.10.1 Nexvet Company Information
10.10.2 Nexvet Introduction and Business Overview
10.10.3 Nexvet Pet Medication Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Nexvet Pet Medication Products Offered
10.10.5 Nexvet Recent Development
10.11 Aratana Therapeutics
10.11.1 Aratana Therapeutics Company Information
10.11.2 Aratana Therapeutics Introduction and Business Overview
10.11.3 Aratana Therapeutics Pet Medication Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Aratana Therapeutics Pet Medication Products Offered
10.11.5 Aratana Therapeutics Recent Development
10.12 Kindred Biosciences
10.12.1 Kindred Biosciences Company Information
10.12.2 Kindred Biosciences Introduction and Business Overview
10.12.3 Kindred Biosciences Pet Medication Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Kindred Biosciences Pet Medication Products Offered
10.12.5 Kindred Biosciences Recent Development
10.13 Ambrx
10.13.1 Ambrx Company Information
10.13.2 Ambrx Introduction and Business Overview
10.13.3 Ambrx Pet Medication Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Ambrx Pet Medication Products Offered
10.13.5 Ambrx Recent Development
10.14 Entest Biomedical
10.14.1 Entest Biomedical Company Information
10.14.2 Entest Biomedical Introduction and Business Overview
10.14.3 Entest Biomedical Pet Medication Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Entest Biomedical Pet Medication Products Offered
10.14.5 Entest Biomedical Recent Development
10.15 Taconic Biosciences
10.15.1 Taconic Biosciences Company Information
10.15.2 Taconic Biosciences Introduction and Business Overview
10.15.3 Taconic Biosciences Pet Medication Sales, Revenue and Gross Margin (2018-2023)
10.15.4 Taconic Biosciences Pet Medication Products Offered
10.15.5 Taconic Biosciences Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Pet Medication Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Pet Medication Industrial Chain Analysis
11.4 Pet Medication Market Dynamics
11.4.1 Pet Medication Industry Trends
11.4.2 Pet Medication Market Drivers
11.4.3 Pet Medication Market Challenges
11.4.4 Pet Medication Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Pet Medication Distributors
12.3 Pet Medication Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock